Panel Discussion: Looking Beyond Amyloid, Tau, TDP43 & Alpha Synuclein, How Can we Validate Biomarkers for Drugs with Alternative Mechanisms?
Time: 3:00 pm
day: Conference Day 2
Details:
- Evaluating how these markers are for TDP43 & Alpha Synuclein across disease?
- Exploring use cases of biomarker usage for neuroinflammatory pathology, microglia and oxidative stress where there is little relevance to the disease indication
- Navigating future directions to improve ease of biomarker utility in drug development
